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Objectives: Clinical trials of either pulmonary perfusion or ventilation during cardio-
pulmonary bypass (CBP) are equivocal. We hypothesized that to achieve significant 
improvement in outcomes both interventions had to be concurrent.
Design: Retrospective case–control study.
settings: Major academic tertiary referral medical center.
Participants: Two hundred seventy-four consecutive patients who underwent open 
heart surgery with CBP 2009–2013.
interventions: The outcomes of 86 patients who received pulmonary perfusion and ven-
tilation during CBP were retrospectively compared to the control group of 188 patients.
Measurements and main results: Respiratory complications rates were similar in both 
groups (33.7 vs. 33.5%), as were the rates of postoperative pneumonia (4.7 vs. 4.3%), 
pleural effusions (13.9 vs. 12.2%), and re-intubations (9.3 vs. 9.1%). Rates of adverse 
postoperative cardiac events including ventricular tachycardia (9.3 vs. 8.5%) and atrial 
fibrillation (33.7 vs. 28.2%) were equivalent in both groups. Incidence of sepsis (8.1 vs. 
5.3%), postoperative stroke (2.3 vs. 2.1%), acute kidney injury (2.3 vs. 3.7%), and renal 
failure (5.8 vs. 3.7%) was likewise comparable. Despite similar transfusion requirements, 
coagulopathy (12.8 vs. 5.3%, p = 0.031) and the need for mediastinal re-exploration 
(17.4 vs. 9.6%, p =  0.0633) were observed more frequently in the pulmonary perfu-
sion and ventilation group, but the difference did not reach the statistical significance. 
Intensive care unit (ICU) and hospital stays, and the ICU readmission rates (7.0 vs. 8.0%) 
were similar in both groups.
conclusion: Simultaneous pulmonary perfusion and ventilation during CBP were not 
associated with improved clinical outcomes.
Keywords: cardiopulmonary bypass, postoperative complications, pulmonary perfusion, pulmonary ventilation, 
cardiac surgery outcome
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inTrODUcTiOn
Pulmonary dysfunction after open heart surgery is multifacto-
rial. The relative contributions of various pathophysiologic 
factors remain obscure despite enormous experimental and 
clinical efforts (1–3). Cessation of alveolar ventilation and per-
fusion engendered in traditional technique of cardiopulmonary 
bypass (CPB) are thought to potentiate the effects of systemic 
inflammatory reaction associated with CPB and to contribute 
to postoperative pulmonary dysfunction. However, despite 
initial enthusiasm, attempts to mitigate iatrogenic atelectasis 
and alveolar ischemia had very limited impact on postopera-
tive pulmonary dysfunction (4–7). We have argued in the past 
(8) that the disappointing inconsistency of these clinical trials 
stemmed from their focus on either pulmonary perfusion or 
ventilation but never on both simultaneously; we had proposed 
that binary interventions of either ventilation of ischemic alveoli 
or perfusion of atelectatic lungs were of unlikely benefit, and 
that to achieve favorable outcomes both interventions had to be 
concurrent; lungs had to be both perfused and ventilated during 
CPB (9). Therefore, we have studied the effects of simultaneous 
pulmonary perfusion and ventilation during CPB in compari-
son to traditional management of CPB. We hypothesized that 
the pulmonary perfusion and ventilation was a safe technique 
that had the potential to reduce the incidence and severity of 
postoperative pulmonary dysfunction in patients undergoing 
open heart surgery.
MaTerials anD MeThODs
Following Institutional Review Board (IRB) approval, the medi-
cal records of 274 consecutive patients who underwent a cardiac 
valve procedure at Jackson Memorial Hospital/University of 
Miami between January 1, 2009 and December 30, 2013 were 
reviewed. No specific criteria were implemented other than 
cardiac surgery requiring CBP during the designated time frame. 
All data were anonymized before analysis. The informed consent 
for this retrospective study was waived.
Data collection
All perioperative data were obtained from the electronic medi-
cal records. The collected data included multiple descriptors of 
patients’ demographics, comorbidities, details of intraoperative 
course, perioperative transfusion requirements, duration of the 
intensive care unit (ICU) and hospital stays, and perioperative 
mortality and morbidity events. Postoperative pulmonary compli-
cations, re-intubation rates, need for postoperative re-exploration 
and transfusion, and adverse neurologic and renal events were all 
included in the analysis.
Outcomes
The outcomes of 86 patients who received pulmonary perfusion 
and ventilation during CPB (cohort of interest) were retrospec-
tively compared to the outcomes of control group of 188 patients 
who had undergone conventional CPB management without 
pulmonary perfusion and ventilation.
The primary outcomes included the in-hospital morbidity 
and mortality rates. Secondary outcome measures included vari-
ous postoperative complications including cardiac, pulmonary, 
neurologic and renal compromise, sepsis, duration of postop-
erative mechanical ventilator support in the ICU, length of ICU 
and hospital stays, and need for re-exploration and transfusion 
requirements.
intraoperative Management of 
cardiopulmonary Bypass
As a matter of surgical preference, in all patients, every attempt 
was made to avoid or to minimize the duration of cardioplegic 
arrest utilizing the “beating heart technique” (10, 11). While 
the systemic circulation was supported by CPB, the unloaded 
(“empty”) beating heart was continuously perfused (both in ante-
grade and retrograde fashion) with warm oxygenated blood. In 
certain circumstances, such as a difficult valve exposure, an exces-
sively bloody field, or a perceived increased risk of embolization, 
cardioplegic arrest was induced. All the decisions regarding the 
administration of hyperkalemic cardioplegia and the duration of 
cardioplegic arrest were made by the surgeon based on the techni-
cal aspects of the surgery.
In the control group, pulmonary ventilation was suspended 
for the duration of the CPB, and no attempt was made to perfuse 
the pulmonary artery. In the cohort of interest, the following 
technique was used: pulmonary ventilation was maintained 
with inspired oxygen fraction (FiO2) of 0.5, tidal volumes of 
4–6 ml/kg of ideal weight, at a rate of 5 breaths/min, and end-
expiratory pressure (PEEP) of 5 mmH2O. The pulmonary artery 
was perfused via a 3-mm diameter perfusion cannula attached 
to the aortic cannula. In this setup, pulmonary artery perfusion 
depended on the CPB flow and pressure, tubing length and resist-
ance, and blood viscosity. At systemic flows of 2.4 l/min/m2 and 
mean arterial pressures of 60 mmHg, Doppler-measured average 
pulmonary arterial flows ranged between 400 and 500 ml/min. 
Presence of the alveolar perfusion was confirmed by steady values 
of end-tidal CO2 on continuous capnography (12). The decision 
to utilize the pulmonary perfusion and ventilation during CPB 
was exclusively the surgeon’s.
statistical analysis
Descriptive statistics were used to describe all variables of 
interest within each of the comparison groups (lung perfu-
sion/ventilation group vs. conventional technique group). Mean 
values and SDs were calculated for continuous variables that 
approximately follow the normal distribution and Student’s 
t-tests were then used to compare the groups. Median values 
and interquartile ranges (IQR) were calculated for variables 
that were highly skewed and Wilcoxon’s rank-sum tests were 
then used for comparison between the groups. Frequencies and 
proportions were used to analyze categorical variables. Chi-
square tests or Fisher’s exact tests were then used depending on 
the expected cell counts, to compare difference in proportions 
between the groups and to examine the overall trends. Due to 
the amount of comparisons performed, a Bonferroni adjusted 
type I error rate of 0.00091 was assumed for significance. All 
TaBle 1 | Demographic data.
Demographic data lung V/Q group (n = 86) conventional (n = 188) stats
Frequency % Frequency % p-Value Test
Gender
Female 35 40.7 88 46.8 0.3453
Male 51 59.3 100 53.2
Smoker 30 34.9 57 30.3 0.4513 c
Diabetes 26 30.2 51 27.1 0.5957 c
HTN 58 67.4 148 78.7 0.0448 c
Dyslipidemia 30 34.9 74 39.4 0.4784 c
PVD 5 5.8 3 1.6 0.1134 f
CVA 17 19.8 19 10.1 0.028 c
Chronic lung disease 19 22.1 35 18.6 0.5021 c
History of renal failure 17 19.8 19 10.1 0.028 c
History of dialysis 10 11.6 8 4.3 0.0223 c
Prior CABG 4 4.6 4 2.1 0.2496 f
Prior valve surgery 15 17.4 15 8.0 0.0199 c
History of prior CAD 11 12.8 10 5.3 0.031 c
Intubated before surgery 3 3.5 10 5.3 0.7605 f
ICU admission before surgery day 31 36.1 39 20.7 0.007 c
N Median iQr N Median iQr p-Value Test
Ejection fraction 82 55 20 179 55 10 0.8858
N Mean sD N Mean sD p-Value Test
Age 86 58.6 15.2 188 57.7 14.1 0.6501
OR, operating room; HTN, hypertension; CVA, cerebrovascular accident; PVD, peripheral vascular disease; CAD, coronary artery disease; CABG, coronary artery bypass graft; ICU, 
intensive care unit; V/Q, pulmonary ventilation and perfusion.
Test: c, chi-square test; f, Fischer’s exact test, p-value (adjusted alpha 0.0009).
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analyses were performed using SAS 9.4 (SAS Institute, Cary, 
NC, USA).
resUlTs
Preoperative demographics and clinical data are summarized 
in Table  1. Baseline demographics were similar between the 
groups. Of the 86 patients who received pulmonary perfusion 
and ventilation during CPB, most were male (59.3%) with 
a mean age of 58  years and a median left ventricular ejection 
fraction (EF) of 55%. Comparably, of 188 patients in the control 
group, most were male (53.2%), with a mean age of 57 and 
EF of 55%. The most common comorbidities in both groups 
included hypertension (67.4 vs. 78.7%), dyslipidemia (34.9 vs. 
39.3%), smoking (35 vs. 30%), diabetes (30 vs. 27%), chronic 
lung disease (22 vs. 19%), and renal disease (19 vs. 10%). Even 
though the patients in the cohort of interest had higher incidence 
of a prior cerebrovascular event (19.7 vs. 10.1%), coronary artery 
disease (12.8 vs. 5.3%), prior coronary artery bypass grafting 
(CABG) (4.7 vs. 2.1%), prior valve surgery (17.4 vs. 7.9%), and 
preoperative ICU admissions (36.1 vs. 20.7%), the difference 
was not statistically significant when Bonferroni correction to 
the p values was applied. Patients in both groups had comparable 
rates of intubation and mechanical ventilation immediately prior 
to the surgery (3.5 vs. 5.3%).
Table 2 specifies the types of surgical procedures and sum-
marizes the intraoperative data. In both groups, single valve 
surgery was the most common (77.9% in the cohort of interest 
vs. 80.9% in the control group); rates of multiple valves surgery 
(10.5  vs.  7.5%) and of combined valve and CABG procedures 
(11.6  vs. 11.7%) were similar in both groups (p  =  0.703). 
Transfusion rates (calculated as fraction of patients requiring at 
least 1 U of autologous blood, %) (94.2 vs. 95.7%) and the average 
duration of surgery (time from the surgical incision to the end of 
surgery) were equal in both groups (4.5 vs. 4.7 h).
Patients who had pulmonary perfusion and ventilation during 
CPB had significantly shorter CPB times (median 88 vs. 119 min, 
p < 0.0001) and higher rates of extubation in the OR (37.2 vs. 
13.8%, p < 0001).
Table  3 summarizes some postoperative events. Overall, 
patients in both groups had similar transfusion requirements 
(calculated as the fraction of patients requiring at least 1  U of 
autologous blood, %) (60.5 vs. 50.5%, p = 0.126), duration of ICU 
(5 vs. 5 days) and hospital stays (9.3 vs. 9.5 days), and the ICU 
readmission rates (7.0 vs. 8.0%).
Postoperative complications are tabulated in Table 4. Overall 
respiratory complications rates were similar in both groups (33.7 
vs. 33.5%), as were the rates of postoperative pneumonia (4.7 
vs. 4.3%), pleural effusions (13.9 vs. 12.2%), and re-intubations 
due to deterioration of pulmonary function (9.3 vs. 9.1%). Rates 
of adverse postoperative cardiac events, such as ventricular 
tachycardia (9.3 vs. 8.5%), atrial fibrillation (33.7 vs. 28.2%), and 
cardiac arrest (11.6 vs. 10.6%), were equivalent in both groups. 
Incidence of sepsis (8.1 vs. 5.3%), new postoperative stroke (2.3 
vs. 2.1%), acute kidney injury (2.3 vs. 3.7%), and renal failure (5.8 
vs. 3.7%) were similar in both groups.
TaBle 4 | Postoperative morbidity and mortality.
Morbidity and mortality events lung V/Q group (n = 86) conventional (n = 188) stats
Frequency % Frequency % p-Value Test
Respiratory 29 33.7 63 33.5 0.9727 c
Atelectasis 20 23.3 37 19.7 0.4987 c
Pneumothorax 4 4.6 13 6.9 0.471 c
Pleural effusion 12 13.9 23 12.2 0.6923 c
Pneumonia 4 4.6 8 4.3 1 f
Pulmonary embolism 0 0 1 0.5 – –
Septic 7 8.1 10 5.3 0.3691 c
Stroke 2 2.3 4 2.1 1 f
AKI 2 2.3 7 3.7 0.7244 f
ARF 5 5.8 7 3.7 0.526 f
Cardiac arrest 10 11.6 20 10.6 0.8077 c
Coagulopathy 11 12.8 10 5.3 0.031 c
Cardiac tamponade 2 2.3 9 4.8 0.5112 f
Atrial fibrillation 29 33.7 53 28.2 0.3537 c
Ventricular arrhythmias 8 9.3 16 8.5 0.8297 c
Re-exploration 15 17.4 18 9.6 0.0633 c
Re-intubation 8 9.3 17 9.0 0.9448 c
Overall mortality 14 16.3 16 8.5 0.056 c
V/Q, ventilation and perfusion; AKI, acute kidney injury; ARF, acute renal failure.
Test: c, chi-square test; f, Fischer’s exact test.
TaBle 3 | Postoperative course.
Postoperative course Pulmonary V/Q group (n = 86) conventional (n = 188) stats
Median iQr Median iQr p-Value
ICU stay, days 5 5 5 5 0.6742
Postoperative hospital stay, days 9.3 12 9.5 7.4 0.3209
Frequency % Frequency % p-Value
Postoperative blood products transfusion 52 60.5 95 50.5 0.126
ICU readmissions 6 6.9 15 7.9 0.7723
ICU, intensive care unit; V/Q, ventilation and perfusion.
p-Value (adjusted alpha 0.0009). All associations involving categorical variables were examined using Chi-square tests or Fisher exact tests.
TaBle 2 | intraoperative data.
intraoperative data lung V/Q group (n = 86) conventional (n = 188) stats
Frequency % Frequency % p-Value
Scheduled procedure 0.703
Single valve 67 77.9 152 80.8
Double/triple valve 9 10.5 14 7.4
CABG plus valve 10 11.6 22 11.7
Intra-op blood products 81 94.2 180 95.7 0.5538a
Extubation in the OR 32 37.2 26 13.8 <0.0001
Median iQr Median iQr p-Value
CPB time, min 88 41 119 75 <0.0001
Time from incision to end of surgery, h 4.5 1.9 4.725 2.5 0.0515
Time from end of surgery to out of OR, min 25 22 25 20 0.3748
OR, operating room; CABG, coronary artery bypass graft; V/Q, pulmonary ventilation and perfusion; CPB, cardiopulmonary bypass; min, minutes.
p-Value (adjusted alpha 0.0009). All associations involving categorical variables were examined using chi-square tests or Fisher exact tests (a).
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Coagulopathy (12.8 vs. 5.3%, p = 0.031) and the need for medi-
astinal re-exploration (17.4 vs. 9.6%, p = 0.0633) were observed 
more frequently in pulmonary perfusion and ventilation group, 
but the difference did not reach the statistical significance.
Table  5 lists the mortality events for both groups. Cardiac 
failure was the leading cause of mortality in patients after pulmo-
nary perfusion and ventilation during CPB (8 out of 14 patients). 
Multisystem organ failure [defined as systemic inflammatory 
TaBle 5 | Mortality events.
Pulmonary perfusion/ventilation group conventional technique
Procedure events Procedure events
MV replacement (endocarditis) Septic shock and multisystem organ 
failure
MV and TV repair + AVR Septic shock and multisystem organ failure
AVR Cardiogenic shock due to 
postoperative MI
MV replacement Sternal wound dehiscence, mediastinitis, sepsis, 
multisystem organ failure
Redo MV replacement 
(preoperative endocarditis)
MRSA bacteremia, septic shock, ARDS Bentall procedure Cardiac arrest
Emergency MV replacement due 
to preoperative MI complicated 
with PM rupture; ECMO
Cardiogenic shock AVR Septic shock and multisystem organ failure
Emergency AVR due to severe 
acute AR and pulmonary edema 
after attempted valvuloplasty
Cardiogenic shock AVR CABGx2 Severe postoperative respiratory failure required 
ECMO
MV replacement Severe paravalvular leak, complicated 
by ARDS
AVR Post-op cardiogenic shock; SIRS, multisystem 
organ failure
MV repair Exacerbation of CHF and ARF due 
to rejection of transplanted kidney, 
cardiogenic shock
AVR CABGx1 Severe postoperative respiratory failure
AVR Massive stroke with irreversible brain 
injury
Emergency MV replacement 
due to endocarditis and stroke
Severe postoperative respiratory failure requiring 
ECMO support, septic shock, multisystem organ 
failure
Emergency AVR CABGx2 due 
to left main coronary occlusion 
and AS
Cardiogenic shock, SIRS complicated 
with multisystem organ failure
AVR CABGx1 Refractory cardiogenic shock
Emergency MV replacement 
CABGx1 due to MI and PM 
rupture
Cardiogenic shock; SIRS complicated 
with multisystem organ failure
AVR, MV replacement due to 
endocarditis following major 
burn injury
ARDS, SIRS, multisystem organ failure
MV replacement Respiratory failure AVR CABGx1 Developed delayed symptomatic lung infiltrates 
requiring re-intubation; succumbed later to 
refractory respiratory failure
MV replacement Cardiogenic shock MV replacement due to 
endocarditis
Sepsis, multisystem organ failure
Emergency TV repair due to 
endocarditis
Postoperative septic shock complicated 
with severe heart failure, required 
postoperative ECMO support
Bentall procedure Postoperative sternal wound infection, sepsis, 
multisystem organ failure
Redo (×3) MV replacement, TV 
repair due to endocarditis
SIRS, multisystem organ failure AVR Cardiogenic shock, unable to wean off CPB, 
postoperative ECMO
AVR Cardiac arrest in the ICU
AVR due to endocarditis Cardiogenic shock
MV, mitral valve; AVR, aortic valve replacement; TV, tricuspid valve; CABGx1, coronary artery bypass grafting, CABGx2, coronary artery bypass grafting, two vessels; one vessel; 
SIRS, systemic inflammatory response syndrome; MRSA, methicillin-resistant Staphylococcus aureus; ARDS, acute respiratory distress syndrome; CPB, cardiopulmonary bypass; 
ECMO, extracorporeal membrane oxygenation.
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response syndrome (SIRS) with or without documented sys-
temic infection] contributed to mortality in four patients, and 
respiratory failure (defined as persistent, severe, and refractory 
hypoxemia) was seen in three patients. In the control group, 8 
out of 16 patients succumbed to septic complications and SIRS 
with multisystem organ failure, 8 to postoperative cardiac failure, 
and 4 to severe respiratory failure. Overall mortality rates, though 
higher in the cohort of interest, were not statistically different 
(16.3 vs. 8.5%, p = 0.056).
DiscUssiOn
Our study failed to demonstrate clinically significant benefits 
of simultaneous pulmonary perfusion and ventilation during 
CPB. These findings are in contrast with Suzuki et  al. (13), 
who reported a significantly shorter duration of postoperative 
mechanical ventilation and improved alveolar function in infants 
who were subjected to 30  ml/kg/min pulmonary artery perfu-
sion flows during CPB in the course of corrective surgery for 
6Rodriguez-Blanco et al. Pulmonary Perfusion and Ventilation during Cardiopulmonary Bypass
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congenital heart disease. Our study was considerably different: 
all patients were adults, “beating heart” technique rather than 
hypothermic hyperkalemic cardiac arrest was used whenever 
possible, and pulmonary perfusion flows were significantly lower 
(close to 500 ml/min). Clinical studies in settings resembling our 
study are less sanguine. Selective continuous pulmonary artery 
perfusion flows of 7  ml/kg/min, comparable to those used in 
our study, in low-risk adult patients during on-bypass coronary 
revascularization resulted in no significant clinical benefits (14, 
15) despite slightly improved pulmonary perfusion indices and 
decreased pulmonary tissue inflammatory cytokine production. 
Importantly, Kiessling et  al. (5) reported an absence of clinical 
benefits despite small trends toward decreased pulmonary 
tissue-generated inflammatory markers in a study of intermittent 
selective pulmonary perfusion in high-risk pulmonary patients 
undergoing on-bypass coronary revascularization. Similar to our 
results, the latter study demonstrated a statistically insignificant 
unfavorable trend toward increased overall mortality and pulmo-
nary morbidity. Animal studies of selective partial pulmonary 
perfusion during CPB reported inconclusive results as well (16), 
citing a low study size and possibly insufficient duration of the 
pulmonary artery perfusion.
Studies of alveolar ventilation during CPB suffer from a simi-
lar dichotomy between in  vivo findings and clinical outcomes. 
In a pig model, Imura et al. (17) demonstrated preservation of 
transalveolar gas change and metabolic and histologic evidence 
of protective effects of low-frequency ventilation on histoarchi-
tecture and function of alveolar membrane. However, these 
protective effects were not clinically evident (6), likely due to 
large data variability and insufficient study size. In an attempt 
to increase the power of these studies, a meta-analysis was per-
formed of 16 clinical trials with a total enrollment of 814 patients 
(7). Various methods of ameliorating iatrogenic atelectasis 
during CPB included continuous positive alveolar pressure, low-
frequency ventilation, and vital capacity recruitment maneuvers. 
Irrespective of the method, the clinical effects were short lived 
and did not impact the outcomes.
Outcome studies of fully maintained pulmonary perfusion 
and ventilation during bypass as in the Drew–Anderson tech-
nique (bilateral extracorporeal circulation without a membrane 
oxygenator, using patients’ lungs as a natural oxygenator) are 
not without controversy as well. Richter et  al. (18) reported a 
significant decrease in inflammatory cytokines with clinically 
significant improvements in hemostasis, postoperative pul-
monary function, and shorter times of mechanical ventilator 
support. However, a recent animal study of the same technique 
(19) did not find any change in inflammatory cytokines produc-
tion by pulmonary tissue despite electron microscopy evidence 
of the mitigating effects of pulmonary perfusion and ventilation 
on polymorphonuclear leukocytes infiltration, interstitial edema 
formation, and histoarchitecture disruption associated with 
conventional CPB.
Translating theoretical concepts into clinical outcomes remains 
an ever-elusive goal. Even such well-established concepts as the 
deleterious effects of inflammatory cytokines still await their cor-
relation with specific clinical end-points. While Siepe et al. (20) 
attributed the protective effects of pulmonary perfusion during 
CPB to the decreased pulmonary tissue expression and blood 
concentration of inflammatory cytokines, such as IL-6, IL-8, 
IL-10, and TNF-α, and others (5, 15, 19) could not reproduce 
these effects. Likewise, despite avoidance of CPB, pulmonary 
atelectasis and activation of inflammatory cascades associ-
ated with pulmonary ischemia–reperfusion injury, off-bypass 
technique of coronary revascularization offers only a modest 
clinical impact on pulmonary outcomes in patients with severe 
pulmonary disease (21–23).
Absence of proof is not a proof of absence. Nevertheless, 
an apparent lack of clinically significant benefits of pulmonary 
perfusion and ventilation during CPB begs for an explanation. 
We could speculate that in a milieu of multiple concurrent 
operational pathophysiologic mechanisms, mitigating some of 
the variables may not translate into an observable clinical effect 
(24). Patients in both groups had comparable incidences of 
non-modifiable risks of postoperative pulmonary dysfunction 
and ventilator dependency such as advanced age, reduced preop-
erative pulmonary function, smoking, renal insufficiency, recent 
myocardial infarction, and reduced left ventricular function. 
Untoward effects of CBP may be confounded by altered pulmo-
nary mechanics due to sternothomy, internal mammary artery 
harvest, pleural entry, and phrenic nerve injury (3, 23, 25–27). 
In the present study, the majority of the patients in both groups 
were exposed to blood products perioperatively, an additional 
and a significant confounding factor associated with a possibility 
of a delayed lung injury (28). There is also a growing appreciation 
for the importance of factors not included in our study, such as 
right ventricular (RV) function and mode of perioperative 
ventilation. Even though RV performance is not included yet 
in STS risk score calculation, it had emerged as an important 
independent factor for perioperative morbidity and mortality in 
some critically ill populations (29, 30). Similarly, the impact of 
ventilation strategies on RV pulmonary blood flow functionality 
and on pulmonary and overall outcomes is increasingly under-
stood and appreciated (31–35). Additionally, the institutional 
structure, and expertise and experience of individual surgeons, 
anesthesiologists, and intensivists (23, 36, 37) may be important, 
but difficult to quantify. While the institutional bias was elimi-
nated in our study, effects of interprovider variability could not 
be reliably ruled out.
Our study suffers from multiple limitations. It is retrospec-
tive and could not be randomized, and strong interprovider 
variability is likely. A small sample size may have prevented the 
detection of some significant differences. Some factors, such as 
RV function and rationale for various decisions and management 
preferences, were not recorded and their contribution to postop-
erative outcomes remains unknown. A retrospective differential 
diagnosis to establish the relative contributions of cardiac and 
pulmonary pathology in mortality events was difficult in many 
cases. Nevertheless, we believe the validity of our study, since the 
largely negative results were obtained despite shorter CPB and 
cross-clamp times and higher rates of extubation in the OR in 
the cohort of interest.
In conclusion, our data failed to demonstrate any clinical 
benefits of simultaneous pulmonary perfusion and ventilation 
during CPB. It underscores the difficulty to translate attractive 
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